Navigation Links
New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline

JACKSON, Miss., Dec. 10 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) delivered a new report on medicines in the research pipeline for major diseases affecting African Americans to Mississippi Governor Haley Barbour today. The report found that America's pharmaceutical research companies are now testing 691 new medicines to help treat diseases that disproportionately affect African Americans or diseases that are among the top 10 causes of death among African Americans. According to the U.S. Census Bureau, Mississippi has the largest (37 percent) African American population in the United States.

"We delivered this report to Governor Barbour because of its relevance to the health of Mississippi's African American population," said Ken Johnson, PhRMA Senior Vice President. "The diseases highlighted in the report, including cancer, diabetes, heart disease and stroke, are among the diseases that disproportionately affect African Americans in Mississippi."

For example, according to state statistics, African Americans in Mississippi have a mortality rate from cardiovascular disease that is 25 percent higher than whites, stroke is 66 percent higher than whites, and African Americans in Mississippi are almost twice as likely as whites to have diabetes.

"There are complex reasons for the health disparity between African Americans and other Americans that are not fully understood," said PhRMA President and CEO Billy Tauzin. "These 691 medicines in development offer hope for closing the troubling health gap and increase the likelihood that every American can share in the benefits of medical progress."

The medicines in development include:

-- 229 medicines for cancers that disproportionately affect African Americans. According to the American Cancer Society, African Americans have the highest mortality rate of any racial and ethnic group for all cancers combined.

-- 114 medicines designed to treat cardiovascular disease. According to the American Heart Association, African Americans have the highest prevalence rate of high blood pressure in the world.

-- 95 medicines in development for diabetes. According to the American Diabetes Association, African Americans are nearly two times more likely to have diabetes compared with whites.

-- 77 medicines for respiratory disorders, including asthma. According to the American Lung Association, African Americans have the highest asthma rate of any other racial and ethnic group. They are also three times more likely to die from asthma than whites.

-- 67 medicines that target HIV infection. Although the overall estimated numbers of new HIV infections have been decreasing, African Americans accounted for 49 percent of cases of HIV infection diagnosed in 2005, according to the U.S. Centers for Disease Control and Prevention.

Other medicines in development tackle kidney disease, glaucoma, obesity, and sickle cell disease.

To read the report on the PhRMA Web site, click on the following link:

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $43 billion in 2006 in discovering and developing new medicines. Industry wide research and investment reached a record $55.2 billion in 2006.

PhRMA Internet Address:

For information on stories of hope and survival, visit:

For information on how innovative medicines save lives, visit:

For information on the Partnership for Prescription Assistance, visit:

For information on the danger of imported drugs, visit:

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
Breaking Medicine Technology:
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
Breaking Medicine News(10 mins):